Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: A systematic review and meta-analysis

Transplant Infectious Disease

Volumn 13, Issue 5, 2011, Pages 441-447

  Green, H ^a,b   Rahamimov, R ^a   Gafter, U ^a,b   Leibovitci, L ^a,b   Paul, M ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Prophylaxis; Renal transplantation; Urinary tract infection

Indexed keywords

AMPICILLIN; CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLONE;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIURIA; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; META ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEPSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; HUMANS; KIDNEY TRANSPLANTATION; URINARY TRACT INFECTIONS;

EID: 80053578281     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00644.x     Document Type: Review

References (25)

1. Di Cocco P, Orlando G, Mazzotta C, et al. Incidence of urinary tract infections caused by germs resistant to antibiotics commonly used after renal transplantation. Transplant Proc 2008; 40 (6): 1881-1884.
2. Lyerova L, Viklicky O, Nemcova D, Teplan V. The incidence of infectious diseases after renal transplantation: a single-centre experience. Int J Antimicrob Agents 2007; 31 (Suppl 1): s58-s62.
3. Maraha B, Bonten H, van Hooff H, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infect 2001; 7 (11): 619-625.
4. Sharifian M, Rees L, Trompeter RS. High incidence of bacteruria following renal transplantation in children. Nephrol Dial Transplant 1998; 13 (2): 432-435.
5. Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant 2005; 19 (2): 230-235.
6. Abbott KC, Swanson SJ, Richter ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004; 44 (2): 353-362.
7. Veroux M, Giuffrida G, Corona D, et al. Infective complications in renal allograft recipients: epidemiology and outcome. Transplant Proc 2008; 40 (6): 1873-1876.
8. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006; 8 (3): 140-147.
9. Schmaldienst S, Dittrich E, Hörl WH. Urinary tract infections after renal transplantation. Curr Opin Urol 2002; 12 (2): 125-130.
10. Abbott KC, Oliver JD 3rd, Hypolite I, et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 2001; 21 (2): 120-127.
11. Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary tract infections in renal transplant recipients. Transplant Proc 2006; 38 (8): 2414-2415.
12. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical center in Israel. Int J Antimicrob Agents 2007; 30 (6): 525-529.
13. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 [update September 2009]. In: The Cochrane Library. Chichester, UK: John Wiley& Sons, Ltd, 2009.
14. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
15. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990; 89 (3): 255-274.
16. Maki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. J Lab Clin Med 1992; 119 (1): 11-24.
17. Hibberd PL, Tolkoff-Rubin NE, Doran M, et al. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized, controlled trial. Online J Curr Clin Trials 1992 Aug 11, Doc. 15.
18. Khosroshahi HT, Mogaddam AN, Shoja MM. Efficacy of high-dose trimethoprim-sulfamethoxazole prophylaxis on early urinary tract infection after renal transplantation. Transplant Proc 2006; 38 (7): 2062-2064.
19. Maddux MS, Veremis SA, Bauma WD, Pollak R, Mozes MF. Effective prophylaxis of early post-transplant urinary tract infections (UTI) in the cyclosporine (CSA) era. Transplant Proc 1989; 21 (1, Part 2): 2108-2109.
20. Moyses Neto M, Costa RS, Reis MA, et al. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients. Clin Transplant 1997; 11 (5 Part 1): 446-452.
21. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipient. Rev Infect Dis 1982; 4 (2): 614-618.
22. Ciszek M, Paczek L, Bartlomiejczyk I, Mucha K. Urine cytokines profile in renal transplant patients with asymptomatic bacteruria. Transplantation 2006; 81 (12): 1653-1657.
23. Moradi M, Abbasi M, Moradi A, Boskabadi A, Jalali A. Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urol J 2005; 2 (1): 32-35.
24. Wilson CH, Bhatti AA, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2005; 19 (4): CD004925.
25. Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008; 68 (Suppl 1): 3-10.